**Core Concept:** P. vivax malaria is a type of malaria caused by the Plasmodium vivax parasite. Treatment options for pregnant women require careful consideration of safety for both the mother and the developing fetus.

**Why the Correct Answer is Right:**

DHA (Dihydroartemisinin) and PQ (Pegylated Piperaquine) combination is the recommended drug of choice for the treatment of P. vivax malaria in pregnant women. This combination has shown to have high efficacy in treating malaria, with minimal side effects on both the mother and the fetus. It is considered safe during pregnancy as it has been extensively studied and approved for use in this population.

**Why Each Wrong Option is Incorrect:**

A. Quinine: Quinine is an older antimalarial drug, and its use in pregnancy is associated with severe side effects, including fetal distress and low birth weight. It is not recommended for treating malaria in pregnant women.

B. Chloroquine: Chloroquine is not effective against P. vivax malaria and is contraindicated in pregnancy due to the risk of retinopathy and other severe side effects.

C. Atovaquone-proguanil: While Atovaquone-proguanil is effective for treating malaria, it is not recommended during pregnancy due to the risk of fetal toxicity.

D. Artemisinin combination therapies (ACTs): ACTs are a class of antimalarial drugs that are highly effective for treating malaria. However, ACTs are not specifically recommended for treating P. vivax malaria in pregnant women due to limited data on safety and efficacy.

**Clinical Pearl:** In a clinical scenario, it is essential to consider the specific characteristics of the malaria species, as well as the potential risks associated with different drug options in pregnancy. This ensures safe and effective treatment for the patient while minimizing risks to the fetus.

**Correct Answer:** DHA and PQ combination (DHA-PQ) is the recommended drug of choice for the treatment of P. vivax malaria in pregnant women. This combination has been extensively studied and approved for use in pregnancy, reducing the risk of severe side effects on both the mother and the fetus.